Results 171 to 180 of about 1,389,605 (343)

The correlation and conservation of forces a series of expositions, by Prof. Grove, Prof. Helmholtz, Dr. Mayer, Dr. Faraday, Prof. Liebig and Dr. Carpenter. With an introduction and brief biographical notices of the chief promoters of the new views

Edward Livingston Youmans, Hermann von Helmholtz, Julius Robert Mayer, Michael Faraday, Justus Liebig, William Benjamin Carpenter, George Carey Foster, W.R. Grove, Heinrich Debus, John Tyndall   +9 more
openalex   +2 more sources

Ubiquitination of transcription factors in cancer: unveiling therapeutic potential

Molecular Oncology, EarlyView.
In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley   +1 more source

Promoter polymorphisms in the JK*01 W.06 allele associated with the Jk(a + ^w) weak antigen phenotype. [PDF]

BMC Immunol
Liang S, Wu F, Jiang R, Liu T, Sun L, Tang R, Dang Y, Deng Z.   +7 more
europepmc   +1 more source

Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription

Proceedings of the National Academy of Sciences of the United States of America, 2002
Adam Siddiqui-Jain, C. Grand, D. Bearss, L. Hurley   +3 more
semanticscholar   +1 more source

Aberrant expression of nuclear prothymosin α contributes to epithelial‐mesenchymal transition in lung cancer

Molecular Oncology, EarlyView.
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen, Chung‐Teng Wang, Jia‐Ming Chang, Ai‐Li Shiau, Gia‐Shing Shieh, Yau‐Lin Tseng, Yi‐Ting Yen, Tang‐Hsiu Huang, Li‐Hsin Cheng, Yu‐Chih Wu, Chao‐Liang Wu, Bing‐Hua Su, Pensee Wu   +12 more
wiley   +1 more source

MYO1G promoter hypomethylation correlates with its mRNA expression, lymphocyte infiltration, and immunotherapy response in melanoma. [PDF]

Front Oncol
Xia Y, Zhang Y, Zheng C, Wang J, Di W, Zhang M, Yang M.   +6 more
europepmc   +1 more source

Dissociation of tumor promoter-stimulated ornithine decarboxylase activity and DNA synthesis in mouse epidermis in vivo and in vitro by fluocinolone acetonide, a tumor-promotion inhibitor. [PDF]

, 1977
Ulrike Lichti, Thomas J. Slaga, Theresa Ben, Elizabeth Patterson, Henry Hennings, Yuspa Sh   +5 more
openalex   +1 more source

Product promotion promotes uptake [PDF]

Nature Energy, 2019
openaire   +1 more source

Does Porphyromonas gingivalis truly inhibit the oral carcinogenesis?

Molecular Oncology, EarlyView.
 
Chen‐xi Li, Zhong‐cheng Gong
wiley   +1 more source

The Single Nucleotide Substitution T → A rs2072580 Damages the CREB1 Binding Site in the Bidirectional <i>SART3</i>/<i>ISCU</i> Promoter. [PDF]

Genes (Basel)
Degtyareva A, Antontseva E, Evseenko A, Orishchenko K, Merkulova T.   +4 more
europepmc   +1 more source